Literature DB >> 19914088

Blockade of multiple but not single cytokines abrogates downregulation of angiotensin II type-I receptors and anticipates septic shock.

Christoph Schmidt1, Klaus Höcherl, Birgül Kurt, Stefan Moritz, Armin Kurtz, Michael Bucher.   

Abstract

In this prospective, randomized animal study, the role of proinflammatory cytokines in the pathogenesis sepsis-induced circulatory failure with downregulation of angiotensin-II-type-I-(AT(1))-receptors was investigated. Sepsis in wild-type mice and in mice with deficiencies for TNF-alpha, IL-1beta, IFN-gamma or IL-6 was induced by cecal ligation and puncture (CLP) and wild-type mice were injected with cytokines. Animals were treated with glucocorticoids or small interfering RNA (siRNA) targeting single or multiple cytokines or NF-kappaB. Vascular smooth muscle cells (VSMCs) were incubated with cytokines. CLP resulted in circulatory failure and a significant downregulation of AT(1)-receptors. Injection of single proinflammatory cytokines also strongly downregulated AT(1)-receptors paralleled by a markedly endogenous liberation of further cytokines, whereas, simultaneous blockade of these endogenously activated cytokines by dexamethasone prevented downregulation of AT(1)-receptors. Furthermore, inhibition of multiple but not single cytokines by treatment with siRNA against multiple cytokines or NF-kappaB significantly attenuated CLP-induced AT(1)-receptor downregulation and prevented septic circulatory failure. Our data demonstrate that downregulation of AT(1)-receptors during sepsis is due to multiple but not single cytokines and define a relevant role for NF-kappaB in the pathogenesis of septic shock. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19914088     DOI: 10.1016/j.cyto.2009.10.006

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  10 in total

1.  Interleukin-6, -7, -8 and -10 predict outcome in acute myocardial infarction complicated by cardiogenic shock.

Authors:  Roland Prondzinsky; Susanne Unverzagt; Henning Lemm; Nikolas-Arne Wegener; Axel Schlitt; Konstantin M Heinroth; Sebastian Dietz; Ute Buerke; Patrick Kellner; Harald Loppnow; Martin G Fiedler; Joachim Thiery; Karl Werdan; Michael Buerke
Journal:  Clin Res Cardiol       Date:  2012-01-03       Impact factor: 5.460

Review 2.  Treating the host response to emerging virus diseases: lessons learned from sepsis, pneumonia, influenza and Ebola.

Authors:  David S Fedson
Journal:  Ann Transl Med       Date:  2016-11

3.  The renal vasodilatory effect of prostaglandins is ameliorated in isolated-perfused kidneys of endotoxemic mice.

Authors:  Manuel Meurer; Katharina Ebert; Frank Schweda; Klaus Höcherl
Journal:  Pflugers Arch       Date:  2018-07-19       Impact factor: 3.657

4.  Effects of angiotensin II type 1 receptor antagonist on rats with septic shock.

Authors:  Jianrong Guo; Wei Guo; Xiaoju Jin; Yang Liu; Lei Zhang; Jianping Zhang
Journal:  Int J Clin Exp Med       Date:  2015-05-15

Review 5.  Bench-to-bedside review: Ventilation-induced renal injury through systemic mediator release--just theory or a causal relationship?

Authors:  Jan Willem Kuiper; Rosanna Vaschetto; Francesco Della Corte; Frans B Plötz; A B Johan Groeneveld
Journal:  Crit Care       Date:  2011-08-16       Impact factor: 9.097

6.  Relative versus absolute RNA quantification: a comparative analysis based on the example of endothelial expression of vasoactive receptors.

Authors:  Kevin Kuhlmann; Melanie Cieselski; Julia Schumann
Journal:  Biol Proced Online       Date:  2021-02-14       Impact factor: 3.244

7.  Severe sepsis: Low expression of the renin-angiotensin system is associated with poor prognosis.

Authors:  Wei Zhang; Xiaowei Chen; Ling Huang; Ning Lu; Lei Zhou; Guojie Wu; Yuguo Chen
Journal:  Exp Ther Med       Date:  2014-02-20       Impact factor: 2.447

Review 8.  Angiotensin in Critical Care.

Authors:  Anna Hall; Laurence W Busse; Marlies Ostermann
Journal:  Crit Care       Date:  2018-03-20       Impact factor: 9.097

Review 9.  Angiotensin II: a new therapeutic option for vasodilatory shock.

Authors:  Rachel L Bussard; Laurence W Busse
Journal:  Ther Clin Risk Manag       Date:  2018-07-26       Impact factor: 2.423

Review 10.  Vasoplegia in patients with sepsis and septic shock: pathways and mechanisms.

Authors:  A-M Burgdorff; M Bucher; J Schumann
Journal:  J Int Med Res       Date:  2018-01-14       Impact factor: 1.671

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.